Dopamine, the kidney, and hypertension

Current Hypertension Reports

Volumn 14, Issue 2, 2012, Pages 138-143

  Harris, Raymond C ^a,b   Zhang, Ming Zhi ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Angiotensin; Blood pressure; Dopamine; Dopaminergic system; G protein receptor kinases; GRK4; Hypertension; Kidney; Salt sensitive hypertension

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; DOPAMINE; DOPAMINE RECEPTOR; G PROTEIN RECEPTOR KINASE 4; PROTEIN KINASE; UNCLASSIFIED DRUG;

ARTICLE; BLOOD PRESSURE REGULATION; DOPAMINERGIC SYSTEM; ENZYME ACTIVITY; ESSENTIAL HYPERTENSION; HUMAN; KIDNEY FUNCTION; MOLECULAR INTERACTION; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; REGULATORY MECHANISM; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SIGNAL TRANSDUCTION;

BLOOD PRESSURE; DOPAMINE; DOPAMINERGIC NEURONS; G-PROTEIN-COUPLED RECEPTOR KINASE 4; HUMANS; HYPERTENSION; KIDNEY; RENIN-ANGIOTENSIN SYSTEM; SIGNAL TRANSDUCTION;

EID: 84862782653     PISSN: 15226417     EISSN: 15343111     Source Type: Journal    
DOI: 10.1007/s11906-012-0253-z     Document Type: Article

References (71)

1. Felder RA, Jose PA. Mechanisms of disease: the role of GRK4 in the etiology of essential hypertension and salt sensitivity. Nat Clin Pract Nephrol. 2006;2:637-50. (Pubitemid 44655641)
2. Zeng C, Jose PA. Dopamine receptors: important antihypertensive counterbalance against hypertensive factors. Hypertension. 57:11-7.
3. Quinones H, Collazo R, Moe OW. The dopamine precursor Ldihydroxyphenylalanine is transported by the amino acid transporters rBAT and LAT2 in renal cortex. Am J Physiol Renal Physiol. 2004;287:F74-80. (Pubitemid 38780585)
4. Pinho MJ, Serrao MP, Soares-da-Silva P. High-salt intake and the renal expression of amino acid transporters in spontaneously hypertensive rats. Am J Physiol Renal. 2007;292:F1452-63. (Pubitemid 46701873)
5. Hayashi M, Yamaji Y, Kitajima W, Saruta T. Aromatic L-amino acid decarboxylase activity along the rat nephron. Am J Physiol Renal. 1990;258:F28-33. (Pubitemid 20063065)
6. Bertorello A, Hokfelt T, Goldstein M, et al. Proximal tubule Na+?K+?ATPase activity is inhibited during high-salt diet: evidence for DA-mediated effect. Am J Physiol Renal. 1988;254:F795-801.
7. Baines AD. Effects of salt intake and renal denervation on catecholamine catabolism and excretion. Kidney Int. 1982;21:316-22. (Pubitemid 12136666)
8. Bacic D, Capuano P, Baum M, et al. Activation of dopamine D1- like receptors induces acute internalization of the renal Na+/phosphate cotransporter NaPi-IIa in mouse kidney and OK cells. Am J Physiol Renal Physiol. 2005;288:F740-7. (Pubitemid 40381741)
9. Grider JS, Ott CE, Jackson BA. Dopamine D1 receptor-dependent inhibition of NaCl transport in the rat thick ascending limb: mechanism of action. Eur J Pharmacol. 2003;473:185-90. (Pubitemid 36929883)
10. Schafer JA. Abnormal regulation of ENaC: syndromes of salt retention and salt wasting by the collecting duct. Am J Physiol Renal Physiol. 2002;283:F221-35. (Pubitemid 34778984)
11. Wang X, Luo Y, Escano CS, Yang Z, et al. Upregulation of renal sodium transporters in D5 dopamine receptor-deficient mice. Hypertension. 2010; 55:1431-1437.
12. Zeng C, Jose PA. Dopamine receptors: important antihypertensive counterbalance against hypertensive factors. Hypertension. 2011;57:11-7.
13. Zeng C, Sanada H, Watanabe H, et al. Functional genomics of the dopaminergic system in hypertension. Physiol Genom. 2004;19:233-46.
14. Needleman P, Turk J, Jakschik BA, et al. Arachidonic acid metabolism. Ann Rev Biochem. 1986;55:69-102. (Pubitemid 16070764)
15. Horton R, Bughi S, Jost-Vu E, et al. Effect of dopamine on renal blood flow, prostaglandins, renin and electrolyte excretion in normal and hypertensive humans. Am J Hypertens. 1990;3:108S-11S. (Pubitemid 20380237)
16. Huo TL, Grenader A, Blandina P, et al. Prostaglandin E2 production in rat IMCD cells. II. Possible role for locally formed dopamine. Am J Physiol. 1991;261:F655-62.
17. Yao B, Harris RC. MZ: Intrarenal dopamine attenuates deoxycorticosterone acetate/high salt-induced blood pressure elevation in part through activation of a medullary cyclooxygenase 2 pathway. Hypertension. 2009;54:1077-83.
18. Harris RC. An update on cyclooxygenase-2 expression and metabolites in the kidney. Curr Opin Nephrol Hypertens. 2008;17:64-9. (Pubitemid 350295199)
19. Kurtz A, Della Bruna R, Pratz J, et al. Rat juxtaglomerular cells are endowed with DA-1 dopamine receptors mediating renin release. J Cardiovasc Pharm. 1988;12:658-63.
20. Antonipillai I, BroersMI, LangD. Evidence that specific dopamine-1 receptor activation is involved in dopamine-induced renin release. Hypertension. 1989;13:463-8. (Pubitemid 19132187)
21. Yamaguchi I, Yao L, Sanada H, et al. Dopamine D1A receptors and renin release in rat juxtaglomerular cells. Hypertension. 1997;29:962-8. (Pubitemid 27152466)
22. Zhang MZ, Yao B, Fang X, et al. Intrarenal dopaminergic system regulates renin expression. Hypertension. 2009;53:564-70.
23. Zhang MZ, Yao B, Harris RC. Cross talk between the intrarenal dopaminergic and cyclooxygenase-2 systems. Am J Physiol Renal Physiol. 2005;288:F840-5. (Pubitemid 40381754)
24. Chen CJ, Apparsundaram S, Lokhandwala MF. Intrarenally produced angiotensin II opposes the natriuretic action of the dopamine-1 receptor agonist fenoldopam in rats. J Pharmacol Exp Ther. 1991;256:486-91.
25. Gesek FA, Schoolwerth AC. Hormone responses of proximal Na (+)-H+ exchanger in spontaneously hypertensive rats. Am J Physiol. 1991;261:F526-36.
26. Cheng HF, Becker BN, Harris RC. Dopamine decreases expression of type-1 angiotensin II receptors in renal proximal tubule. J Clin Invest. 1996;97:2745-52. (Pubitemid 26197089)
27. Aperia A, Holtback U, et al. Activation/deactivation of renal Na+, K(+)-ATPase: a final common pathway for regulation of natriuresis. FASEB J. 1994;8:436-9. (Pubitemid 24155957)
28. Zeng C, Liu Y, Wang Z, et al. Activation of D3 dopamine receptor decreases angiotensin II type 1 receptor expression in rat renal proximal tubule cells. Circ Res. 2006;99:494-500. (Pubitemid 44337821)
29. Zeng C, Yang Z, Wang Z, et al. Interaction of angiotensin II type 1 and D5 dopamine receptors in renal proximal tubule cells. Hypertension. 2005;45:804-10. (Pubitemid 40418385)
30. Stegbauer J, Coffman TM. New insights into angiotensin receptor actions: from blood pressure to aging. Curr Opin Nephrol Hypertens. 2011;20:84-8.
31. Zhang MZ, Yao B, Wang S, et al. Intrarenal dopamine deficiency leads to hypertension and decreased longevity in mice. J Clin Invest. 2011;121:2845-54.
32. Salomone LJ, Howell NL, McGrath HE, et al. Intrarenal dopamine D1-like receptor stimulation induces natriuresis via an angiotensin type-2 receptor mechanism. Hypertension. 2007;49:155-61. (Pubitemid 46360355)
33. Benigni A, Corna D, Zoja C, et al. Disruption of the Ang II type 1 receptor promotes longevity in mice. J Clin Invest. 2009;119:524-30.
34. Yasunari K, Kohno M, Kano H, et al. Dopamine as a novel antioxidative agent for rat vascular smooth muscle cells through dopamine D(1)-like receptors. Circulation. 2000;101:2302-8. (Pubitemid 30317134)
35. Yang Z, Asico LD, Yu P, et al. D5 dopamine receptor regulation of reactive oxygen species production, NADPH oxidase, and blood pressure. Am J Physiol Regul Integr Comp Physiol. 2006;290: R96-R104.
36. Armando I, Wang X, Villar VA, et al. Reactive oxygen speciesdependent hypertension in dopamine D2 receptor-deficient mice. Hypertension. 2007;49:672-8.
37. Yang Z, Asico LD, Yu P, et al. D5 dopamine receptor regulation of reactive oxygen species production, NADPH oxidase, and blood pressure. Am J Physiol Regul Integr Comp Physiol. 2006;290: R96-R104.
38. Helkamaa T, Mannisto PT, Rauhala P, et al. Resistance to saltinduced hypertension in catechol-O-methyltransferase-gene-disrupted mice. J Hypertens. 2003;21:2365-74. (Pubitemid 38293577)
39. Sidhu A, Kumar U, Uh M, Patel S. Diminished expression of renal dopamine D1A receptors in the kidney inner medulla of the spontaneously hypertensive rat. J Hypertens. 1998;16:601-8. (Pubitemid 28230548)
40. Asico L, Zhang X, Jiang J, et al. lack of renal dopamine D5 receptors promotes hypertension. JASN. 2011;22:82-9.
41. Shikuma R, Yoshimura M, Kambara S, et al. Dopaminergic modulation of salt sensitivity in patients with essential hypertension. Life Sci. 1986;38:915-21. (Pubitemid 16107548)
42. Jose PA, Soares-da-Silva P, Eisner GM, et al. Dopamine and G protein-coupled receptor kinase 4 in the kidney: role in blood pressure regulation. Biochim Biophys Acta. 2010;1802:1259-67.
43. Zeng C, Wang D, Asico LD, et al. Aberrant D1 and D3 dopamine receptor transregulation in hypertension. Hypertension. 2004;43:654-60. (Pubitemid 38282443)
44. Jose PA, Eisner GM, Felder RA. Dopaminergic defect in hypertension. Pediatr Nephrol. 1993;7:859-64. (Pubitemid 24010794)
45. Felder RA, Sanada H, Xu J, et al. G protein-coupled receptor kinase 4 gene variants in human essential hypertension. Proc Natl Acad Sci USA. 2002;99:3872-7. (Pubitemid 34252198)
46. Premont RT, Macrae AD, Aparicio SA, et al. The GRK4 subfamily of G protein-coupled receptor kinases. Alternative splicing, gene organization, and sequence conservation. J Biol Chem. 1999;274:29381-9.
47. Nishi A, Eklof AC, Bertorello AM, et al. Dopamine regulation of renal Na+, K(+)-ATPase activity is lacking in Dahl salt-sensitive rats. Hypertension. 1993;21:767-71. (Pubitemid 23171638)
48. Hussain T, Lokhandwala MF. Renal dopamine DA1 receptor coupling with G(S) and G(q/11) proteins in spontaneously hypertensive rats. Am J Physiol Renal. 1997;272:F339-46.
49. Debska-Slizien A, Ho P, Drangova R, et al. Endogenous dopamine regulates phosphate reabsorption but not NaKATPase in spontaneously hypertensive rat kidneys. JASN. 1994;5:1125-32. (Pubitemid 24977091)
50. Sanada H, Jose PA, Hazen-Martin D, et al. Dopamine-1 receptor coupling defect in renal proximal tubule cells in hypertension. Hypertension. 1999;33:1036-42. (Pubitemid 29186405)
51. Gildea JJ, Shah I, Weiss R, et al. HK-2 human renal proximal tubule cells as a model for G protein-coupled receptor kinase type 4-mediated dopamine 1 receptor uncoupling. Hypertension. 2010;56:505-11.
52. Villar VA, Jones JE, Armando I, et al. G protein-coupled receptor kinase 4 (GRK4) regulates the phosphorylation and function of the dopamine D3 receptor, J. Biol Chem. 2009;284:21425-34.
53. Sanada H, Yatabe J, Midorikawa S, et al. Amelioration of genetic hypertension by suppression of renal G protein-coupled receptor kinase type 4 expression. Hypertension. 2006;47:1131-9. (Pubitemid 44289171)
54. Allayee H, de Bruin TW, Michelle Dominguez K, et al. Genome scan for blood pressure in Dutch dyslipidemic families reveals linkage to a locus on chromosome 4p. Hypertension. 2001;38:773-8. (Pubitemid 34258669)
55. Chen W, Li S, Srinivasan SR, et al. Autosomal genome scan for loci linked to blood pressure levels and trends since childhood: the Bogalusa Heart Study. Hypertension. 2005;45:954-9. (Pubitemid 40628943)
56. Lohmueller KE, Wong LJ, Mauney MM, et al. Patterns of genetic variation in the hypertension candidate gene GRK4: ethnic variation and haplotype structure. Ann Hum Genet. 2006;70:27-41. (Pubitemid 43355559)
57. Bengra C, Mifflin TE, Khripin Y, et al. Genotyping of essential hypertension single-nucleotide polymorphisms by a homogeneous PCR method with universal energy transfer primers. Clin Chem. 2002;48:2131-40. (Pubitemid 35397554)
58. Speirs HJ, Katyk K, Kumar NN, et al. Association of G-proteincoupled receptor kinase 4 haplotypes, but not HSD3B1 or PTP1B polymorphisms, with essential hypertension. J Hypertens. 2004;22:931-6. (Pubitemid 38680467)
59. Zhu H, Lu Y,Wang X, et al. The G protein-coupled receptor kinase 4 gene affects blood pressure in young normotensive twins. Am J Hypertens. 2006;19:61-6. (Pubitemid 43217035)
60. Sanada H, Yatabe J, Midorikawa S, et al. Single-nucleotide polymorphisms for diagnosis of salt-sensitive hypertension. Clin Chem. 2006;52:352-60.
61. Williams SM, Ritchie MD, Phillips 3rd JA, et al. Multilocus analysis of hypertension: a hierarchical approach. Hum Hered. 2004;57:28-38. (Pubitemid 38608307)
62. Bhatnagar V, O'Connor DT, Brophy VH, et al. G-protein-coupled receptor kinase 4 polymorphisms and blood pressure response to metoprolol among African Americans: sex-specificity and interactions. Am J Hypertens. 2009;22:332-8.
63. Martinez Cantarin MP, Ertel A, Deloach S, et al. Variants in genes involved in functional pathways associated with hypertension in African Americans. Clin Transl Sci. 2010;3:279-86.
64. Rana BK, Insel PA, Payne SH, et al. Population-based sample reveals gene-gender interactions in blood pressure in White Americans. Hypertension. 2007;49:96-106. (Pubitemid 46360347)
65. Staessen JA, Kuznetsova T, Zhang H, et al. Blood pressure and renal sodium handling in relation to genetic variation in the DRD1 promoter and GRK4. Hypertension. 2008;51:1643-50.
66. Harrison M, Maresso K, Broeckel U. Genetic determinants of hypertension: an update. Curr Hypertens Rep. 2008;10:488-95.
67. Newton-Cheh C, Johnson T, Gateva V, et al. Genome-wide association study identifies eight loci associated with blood pressure. Nat Genet. 2009;41:666-76.
68. Levy D, Ehret GB, Rice K, et al. Genome-wide association study of blood pressure and hypertension. Nat Genet. 2009;41:677-87.
69. Adeyemo A, Gerry N, Chen G, et al. A genome-wide association study of hypertension and blood pressure in African Americans. PLoS Genetics. 2009;5:e1000564.
70. Wang Y, O'Connell JR, McArdle PF, et al. Whole-genome association study identifies STK39 as a hypertension susceptibility gene. Proc Natl Acad Sci USA. 2009;106:226-31.
71. Cho YS, Go MJ, Kim YJ, et al. A large-scale genome-wide association study of Asian populations uncovers genetic factors influencing eight quantitative traits. Nat Genet. 2009;41:527-34.